We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » St. Jude Occluder Misses Endpoint, Company Gets Predicted Form 483
St. Jude Occluder Misses Endpoint, Company Gets Predicted Form 483
October 26, 2012
St. Jude Medical announced Thursday that the company’s Amplatzer PFO Occluder has missed its primary endpoint in the RESPECT trial to evaluate the device’s success at reducing recurrent stroke risk.